180 related articles for article (PubMed ID: 9649978)
1. Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice.
Romero J; Fernández-Ruiz JJ; Vela G; Ruiz-Gayo M; Fuentes JA; Ramos JA
Drug Alcohol Depend; 1998 May; 50(3):241-9. PubMed ID: 9649978
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes.
Selley DE; Stark S; Sim LJ; Childers SR
Life Sci; 1996; 59(8):659-68. PubMed ID: 8761016
[TBL] [Abstract][Full Text] [Related]
4. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding.
Sim LJ; Selley DE; Childers SR
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7242-6. PubMed ID: 7638174
[TBL] [Abstract][Full Text] [Related]
5. Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats.
Romero J; Berrendero F; Garcia-Gil L; de la Cruz P; Ramos JA; Fernández-Ruiz JJ
Neuroscience; 1998 Jun; 84(4):1075-83. PubMed ID: 9578396
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide.
Romero J; Berrendero F; García-Gil L; Lin SY; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
Neurochem Int; 1999 Jun; 34(6):473-82. PubMed ID: 10402222
[TBL] [Abstract][Full Text] [Related]
7. AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brain.
Hosohata Y; Quock RM; Hosohata K; Makriyannis A; Consroe P; Roeske WR; Yamamura HI
Eur J Pharmacol; 1997 Feb; 321(1):R1-3. PubMed ID: 9083796
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.
Sim LJ; Hampson RE; Deadwyler SA; Childers SR
J Neurosci; 1996 Dec; 16(24):8057-66. PubMed ID: 8987831
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptor and WIN 55 212-2-stimulated [35S]-GTPgammaS binding in the brain of mu-, delta- and kappa-opioid receptor knockout mice.
Berrendero F; Mendizábal V; Murtra P; Kieffer BL; Maldonado R
Eur J Neurosci; 2003 Oct; 18(8):2197-202. PubMed ID: 14622180
[TBL] [Abstract][Full Text] [Related]
10. Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain.
Breivogel CS; Childers SR; Deadwyler SA; Hampson RE; Vogt LJ; Sim-Selley LJ
J Neurochem; 1999 Dec; 73(6):2447-59. PubMed ID: 10582605
[TBL] [Abstract][Full Text] [Related]
11. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
Sim-Selley LJ; Martin BR
J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
[TBL] [Abstract][Full Text] [Related]
12. Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation.
Selley DE; Rorrer WK; Breivogel CS; Zimmer AM; Zimmer A; Martin BR; Sim-Selley LJ
J Neurochem; 2001 May; 77(4):1048-57. PubMed ID: 11359870
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.
Breivogel CS; Griffin G; Di Marzo V; Martin BR
Mol Pharmacol; 2001 Jul; 60(1):155-63. PubMed ID: 11408610
[TBL] [Abstract][Full Text] [Related]
14. Atypical location of cannabinoid receptors in white matter areas during rat brain development.
Romero J; Garcia-Palomero E; Berrendero F; Garcia-Gil L; Hernandez ML; Ramos JA; Fernández-Ruiz JJ
Synapse; 1997 Jul; 26(3):317-23. PubMed ID: 9183820
[TBL] [Abstract][Full Text] [Related]
15. delta 9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain.
Burkey TH; Quock RM; Consroe P; Roeske WR; Yamamura HI
Eur J Pharmacol; 1997 Apr; 323(2-3):R3-4. PubMed ID: 9128853
[TBL] [Abstract][Full Text] [Related]
16. Regional differences in cannabinoid receptor/G-protein coupling in rat brain.
Breivogel CS; Sim LJ; Childers SR
J Pharmacol Exp Ther; 1997 Sep; 282(3):1632-42. PubMed ID: 9316881
[TBL] [Abstract][Full Text] [Related]
17. Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum.
Sim LJ; Selley DE; Xiao R; Childers SR
Eur J Pharmacol; 1996 Jun; 307(1):97-105. PubMed ID: 8831110
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of cannabinoid receptor agonist-stimulated [35S]GTP gamma S binding in synaptic plasma membrane from chronic ethanol exposed mouse.
Basavarajappa BS; Hungund BL
Brain Res; 1999 Jan; 815(1):89-97. PubMed ID: 9974126
[TBL] [Abstract][Full Text] [Related]
19. Cellular localization of cannabinoid receptors and activated G-proteins in rat anterior cingulate cortex.
Sim-Selley LJ; Vogt LJ; Vogt BA; Childers SR
Life Sci; 2002 Sep; 71(19):2217-26. PubMed ID: 12215369
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity.
Breivogel CS; Selley DE; Childers SR
J Biol Chem; 1998 Jul; 273(27):16865-73. PubMed ID: 9642247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]